CONMED Q2 Earnings and Revenues Beat Estimates, Gross Margin Expands
CNMD's Q2 earnings and revenues beat estimates, while margin growth and solid international sales support a higher 2026 EPS outlook.
CONMED Corporation (CNMD) Q2 2026 Earnings Call Transcript
CONMED Corporation (CNMD) Q2 2026 Earnings Call Transcript
CONMED Q2 Earnings Call Highlights
CONMED NYSE: CNMD reported second-quarter 2026 net sales of $343.5 million, up 0.3% on a reported basis but down 0.5% in constant currency. Organic sales, which exclude the company's exited gastroenterology product offerings, rose 6% year over year and modestly exceeded management's expectations.
Conmed (CNMD) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Conmed (CNMD) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Conmed (CNMD) Q2 Earnings and Revenues Top Estimates
Conmed (CNMD) came out with quarterly earnings of $1.38 per share, beating the Zacks Consensus Estimate of $1.1 per share. This compares to earnings of $1.15 per share a year ago.
CONMED Expands AirSeal Robotic Solution for da Vinci 5 Hex Cannula
CNMD's FDA-expanded AirSeal indication adds da Vinci 5 hex cannula compatibility, supporting broader use across Intuitive Surgical's robotic systems.
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
CNMD is sharpening its focus on AirSeal, Buffalo Filter and BioBrace, betting on higher-growth platforms to drive margin gains and long-term growth.
Is the Options Market Predicting a Spike in CONMED Stock?
Investors need to pay close attention to CNMD stock based on the movements in the options market lately.
CONMED Corporation (CNMD) Q1 2026 Earnings Call Transcript
CONMED Corporation (CNMD) Q1 2026 Earnings Call Transcript
Compared to Estimates, Conmed (CNMD) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Conmed (CNMD) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Conmed (CNMD) Q1 Earnings and Revenues Beat Estimates
Conmed (CNMD) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.82 per share. This compares to earnings of $0.95 per share a year ago.
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
CNMD's high-margin platforms, supply-chain recovery and margin expansion plans support growth, though tariffs and portfolio shifts weigh on near-term results.
